A Fatal Case of Immune Checkpoint Inhibitor-Mediated Myasthenia Gravis, Myositis, and Cardiomyopathy Overlap Syndrome in Urothelial Carcinoma.

Published in: Cancer reports (Hoboken, N.J.) (2024)

Early recognition of high grade irAEs and prompt intervention is essential. Despite the poor prognosis of these overlap syndromes, current recommendations offer little guidance for severe cases and warrant a call for increased awareness and expansion of available therapeutics.

Keyphrases

myasthenia gravis
poor prognosis
high grade
long non coding rna
low grade
randomized controlled trial
heart failure
small molecule
early onset
clinical practice
drug induced